Genetic Links Between Common Lung Diseases and Lung Cancer Progression: Bioinformatics and Machine Learning Insights

Lung cancer (LC) is one of the most frequently diagnosed cancers and remains the leading cause of cancer-related mortality worldwide, representing a significant global health challenge. While numerous common lung diseases (CLDs) are implicated in LC development, the underlying causes of LC originating from CLDs remain inadequately elucidated. A thorough exploration of LC’s progression from CLDs is essential; our approach integrated bioinformatics and machine learning, utilizing data from GEO and TCGA databases. We began by identifying differentially expressed genes (DEGs) in LC and CLDs, and our gene-disease network revealed for the first time shared DEGs (LC shares significant genes with TB (36), asthma (10), pneumonia (17), COPD (18), and Idiopathic Pulmonary Fibrosis (IPF) (78)), providing insights into potential connections of LC with CLDs. This analysis not only broadened our understanding of their associations but also identified significant pathways and hub proteins (SPTBN1, KCNA4, SCN7A, KCNQ3, GRIA1, and SDC1) through a protein-protein interaction network (PPI). Furthermore, RNA-seq and clinical data were obtained from the cBioPortal portal for shared DEGs of LC and CLDs, assessing their impact on LC patient survival. Integrated mRNA-Seq and clinical data were analyzed via univariate and multivariate Cox Proportional Hazard models to elucidate the influence of significant genes on survival. Furthermore, we developed and deployed a predictive model leveraging the identified hub genes, which demonstrated high accuracy in predicting LC progression. The identified biomarkers and pathways hold promise for further translational research and potential therapeutic targets, advancing understanding of LC development from CLDs. Additionally, co-expression networks among common genes were explored using the Weighted Gene Co-expression Network Analysis (WGCNA). Finally, the hub genes were validated using the Human Protein Atlas (HPA) database and evaluated through various classification algorithms to ascertain their predictive power and diagnostic potential. Doi: 10.28991/ESJ-2025-09-02-021 Full Text: PDF

Authors

Institutions

Publication Details

Journal
Emerging Science Journal
Published
2025-04-01
DOI
https://doi.org/10.28991/esj-2025-09-02-021
Citations
1
Primary Topic
Lung Cancer Treatments and Mutations
Type
article
Field-Weighted Citation Impact
1.52
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Genetic Links Between Common Lung Diseases and Lung Cancer Progression: Bioinformatics and Machine Learning Insights

Md. Zulfiker Mahmud, Ahmed A. Moustafa, Mohammad Zahidur Rahman, Mohammad Ali Moni et al.
1 citations
Emerging Science Journal
Lung Cancer Treatments and Mutations
1.52
article

Genetic Links Between Common Lung Diseases and Lung Cancer Progression: Bioinformatics and Machine Learning Insights

Md. Zulfiker Mahmud, Ahmed A. Moustafa, Mohammad Zahidur Rahman, Mohammad Ali Moni, Md. Ali Hossain, Tania Akter, AKM Azad
article en
1 citations

Abstract

Lung cancer (LC) is one of the most frequently diagnosed cancers and remains the leading cause of cancer-related mortality worldwide, representing a significant global health challenge. While numerous common lung diseases (CLDs) are implicated in LC development, the underlying causes of LC originating from CLDs remain inadequately elucidated. A thorough exploration of LC’s progression from CLDs is essential; our approach integrated bioinformatics and machine learning, utilizing data from GEO and TCGA databases. We began by identifying differentially expressed genes (DEGs) in LC and CLDs, and our gene-disease network revealed for the first time shared DEGs (LC shares significant genes with TB (36), asthma (10), pneumonia (17), COPD (18), and Idiopathic Pulmonary Fibrosis (IPF) (78)), providing insights into potential connections of LC with CLDs. This analysis not only broadened our understanding of their associations but also identified significant pathways and hub proteins (SPTBN1, KCNA4, SCN7A, KCNQ3, GRIA1, and SDC1) through a protein-protein interaction network (PPI). Furthermore, RNA-seq and clinical data were obtained from the cBioPortal portal for shared DEGs of LC and CLDs, assessing their impact on LC patient survival. Integrated mRNA-Seq and clinical data were analyzed via univariate and multivariate Cox Proportional Hazard models to elucidate the influence of significant genes on survival. Furthermore, we developed and deployed a predictive model leveraging the identified hub genes, which demonstrated high accuracy in predicting LC progression. The identified biomarkers and pathways hold promise for further translational research and potential therapeutic targets, advancing understanding of LC development from CLDs. Additionally, co-expression networks among common genes were explored using the Weighted Gene Co-expression Network Analysis (WGCNA). Finally, the hub genes were validated using the Human Protein Atlas (HPA) database and evaluated through various classification algorithms to ascertain their predictive power and diagnostic potential. Doi: 10.28991/ESJ-2025-09-02-021 Full Text: PDF

Emerging Science JournalVol. 9(2)
Imam Mohammad ibn Saud Islamic University (SA), Islamic University (BD), Jagannath University (BD), Jahangirnagar University (BD)
Openalex Percentile: Top 19%
Lung Cancer Treatments and Mutations
1.52
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.